A RETROSPECTIVE COST-EFFECTIVENESS ANALYSIS OF S-AMLODIPINE IN CHINA

被引：2
|
作者：
Hu, S. L. [1 ]
Zhang, Y. [2 ]
He, J. [1 ]
Du, L. [1 ]
机构：
[1] Shanghai Hlth Dev Res Ctr, Shanghai, Peoples R China
[2] Shanghai Inst Technolocy, Shanghai, Peoples R China
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.240
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV14
引用
收藏
页码：A758 / A758
页数：1
相关论文
共 50 条
  • [31] A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China
    Zhuang, Gui-Hua
    Pan, Xin-Juan
    Wang, Xue-Liang
    VACCINE, 2008, 26 (35) : 4608 - 4616
  • [32] Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China
    Chen, Xin-Zu
    Jiang, Kun
    Hu, Jian-Kun
    Zhang, Bo
    Gou, Hong-Feng
    Yang, Kun
    Chen, Zhi-Xin
    Chen, Lia-Ping
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (17) : 2715 - 2722
  • [33] COST-EFFECTIVENESS ANALYSIS OF DIFFERENT TREATMENT STRATEGIES FOR SCHIZOPHRENIA IN CHINA
    Du, X. M.
    Huang, Y.
    VALUE IN HEALTH, 2023, 26 (06) : S126 - S126
  • [34] Measles vaccination of young infants in China: A cost-effectiveness analysis
    Janusz, Cara Bess
    Wagner, Abram L.
    Masters, Nina B.
    Ding, Yaxing
    Zhang, Ying
    Hutton, David W.
    Boulton, Matthew L.
    VACCINE, 2020, 38 (29) : 4616 - 4624
  • [35] China county based COPD screening and cost-effectiveness analysis
    Du, Minghua
    Hu, Hao
    Zhang, Lei
    Liu, Wenpeng
    Chu, Tianbao
    Wu, Guoxia
    Wang, Xiaoling
    Li, Ling
    Wang, Jing
    Zheng, Lingling
    Bai, Shuchen
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (04) : 4652 - 4660
  • [36] COST-EFFECTIVENESS ANALYSIS OF AMISULPRIDE AND OLANZAPINE FOR PATIENTS WITH SCHIZOPHRENIA IN CHINA
    Men, P.
    Yi, Z.
    Li, C.
    Qu, S.
    Xiong, T.
    Yu, X.
    Zhai, S.
    VALUE IN HEALTH, 2018, 21 : S185 - S185
  • [37] COST-EFFECTIVENESS ANALYSIS OF PNEUMOCOCCAL CONJUGATE VACCINATION IN URBAN CHINA
    Liu, G.
    Zhu, L.
    Deng, J.
    Fu, Y.
    Chu, Y.
    Jin, X.
    Shi, Q.
    VALUE IN HEALTH, 2013, 16 (03) : A90 - A90
  • [38] COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN CHINA
    Zhang, Y.
    Yang, L.
    Dong, P.
    Xie, X.
    Tang, B.
    VALUE IN HEALTH, 2012, 15 (07) : A673 - A673
  • [39] COST-EFFECTIVENESS ANALYSIS OF FAMPRIDINE FOR MULTIPLE SCLEROSIS TREATMENT IN CHINA
    Zhao, X.
    Yang, H.
    Zhao, J.
    Wei, T.
    Liu, J.
    VALUE IN HEALTH, 2022, 25 (07) : S413 - S413
  • [40] COST-EFFECTIVENESS ANALYSIS OF IMRECOXIB, CELECOXIB AND DICLOFENAC IN OSTEOARTHRITIS IN CHINA
    Sun, X.
    Hu, X.
    Zhen, X.
    Li, Y.
    Gu, Y.
    Zhao, Z.
    Dong, H.
    VALUE IN HEALTH, 2020, 23 : S152 - S153
12345